Professional Documents
Culture Documents
The effort and expense required to conduct cohort studies have been justified
by the results of several well-known studies. One of these is the Framingham
study, which began in 1948 and still continues. It is a study of samples of the
population of Framingham, Massachusetts, in which several risk factors
associated with coronary heart disease, other cardiovascular diseases, and more
recently, several other chronic diseases, have been assessed. This and several
other cohort studies have clarified our understanding of the principal risk
factors for coronary heart disease, such as elevated serum lipids, high blood
pressure, and cigarette smoking. Other well-known cohort studies include the
long-term follow-up of a cohort of male British doctors who were first asked
about their smoking habits in 1951. After 20 years, the death rates from lung
cancer, other respiratory system cancers, chronic obstructive lung disease, and
coronary heart disease all showed significant differences related to smoking
habits among this large cohort (Doll and Peto 1976).
As noted above, cohort studies are more powerful than case-control studies but
they have some disadvantages. Strengths include the following: complete data
on cases, stages, exposures; can study more than one effect of exposure; can
calculate and compare rates and risks; choice of factors available for study;
quality control of data; can accommodate "nested" case-control study.
Weaknesses include the following: must study large numbers; usually takes
many years, even decades; circumstances may change during study; expensive
in money, skilled staff required; incomplete control of extraneous factors;
rarely possible to study disease mechanism.
Cohort studies are sometimes called prospective or longitudinal studies. It is
important to emphasize that a cohort study, like a case-control study, is not an
experiment, but merely observes the subjects of the study without intervening
—except to ask questions or conduct physical examinations and laboratory tests
at various intervals. Obviously, the informed consent of all participants must be
obtained, and in cohort studies of very long duration it is usually necessary to
obtain informed consent before each subsequent phase of the study.